IOL Chemicals and Pharmaceuticals Limited (BOM:524164)
74.44
-1.03 (-1.36%)
At close: Feb 12, 2026
BOM:524164 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 781.7 | 76.9 | 13.9 | 32.3 | 323.4 |
Short-Term Investments | - | 1,308 | 1,348 | 170.2 | 1,163 | 3,041 |
Trading Asset Securities | - | 3.1 | 2.9 | 2.3 | 2.2 | 2 |
Cash & Short-Term Investments | 1,718 | 2,093 | 1,428 | 186.4 | 1,197 | 3,366 |
Cash Growth | 11.50% | 46.60% | 665.88% | -84.43% | -64.43% | 157.34% |
Accounts Receivable | - | 5,137 | 4,712 | 5,053 | 4,698 | 3,003 |
Other Receivables | - | 193.7 | 176.4 | 231.5 | 231.2 | 334.5 |
Receivables | - | 5,343 | 4,899 | 5,292 | 4,934 | 3,340 |
Inventory | - | 3,606 | 4,248 | 3,255 | 4,099 | 2,952 |
Prepaid Expenses | - | 78.8 | 134.2 | 82 | 78.9 | 50.6 |
Other Current Assets | - | 392.7 | 489 | 388.7 | 499.4 | 514.8 |
Total Current Assets | - | 11,513 | 11,198 | 9,204 | 10,808 | 10,223 |
Property, Plant & Equipment | - | 11,792 | 10,214 | 8,326 | 6,625 | 5,604 |
Long-Term Investments | - | 250.5 | 657.5 | 2,482 | 2,037 | 196.8 |
Other Intangible Assets | - | 134.6 | 126.1 | 88.9 | 33.5 | 2.1 |
Other Long-Term Assets | - | 130.4 | 248.8 | 121.4 | 119.3 | 74.9 |
Total Assets | - | 23,821 | 22,444 | 20,221 | 19,623 | 16,101 |
Accounts Payable | - | 4,276 | 4,692 | 3,142 | 4,093 | 2,388 |
Accrued Expenses | - | 109.2 | 110.4 | 152.3 | 143.3 | 276.1 |
Short-Term Debt | - | 1,170 | 327.6 | 796.3 | 427.5 | - |
Current Portion of Leases | - | - | - | 1.8 | 10.2 | 9 |
Current Income Taxes Payable | - | - | - | - | - | 46.6 |
Current Unearned Revenue | - | 0.4 | 1 | 1.1 | 3.6 | 1.3 |
Other Current Liabilities | - | 543.5 | 469.2 | 468.9 | 456.5 | 184.2 |
Total Current Liabilities | - | 6,099 | 5,600 | 4,563 | 5,134 | 2,906 |
Long-Term Leases | - | - | - | - | 1.8 | 18.3 |
Long-Term Unearned Revenue | - | - | 0.4 | 1.4 | 2.5 | 3.8 |
Pension & Post-Retirement Benefits | - | 47.3 | 54.4 | 1.3 | 10.7 | 20.1 |
Long-Term Deferred Tax Liabilities | - | 778.1 | 661.4 | 563.6 | 531.8 | 532.2 |
Other Long-Term Liabilities | - | 19.6 | 12.7 | 15.2 | 19.4 | 16.7 |
Total Liabilities | - | 6,944 | 6,329 | 5,144 | 5,700 | 3,497 |
Common Stock | - | 587.1 | 587.1 | 587.1 | 587.1 | 587.1 |
Additional Paid-In Capital | - | 2,257 | 2,257 | 2,257 | 2,257 | 2,257 |
Retained Earnings | - | 14,021 | 13,245 | 12,194 | 11,038 | 9,713 |
Comprehensive Income & Other | - | 11.6 | 26 | 38.9 | 40.9 | 46.9 |
Shareholders' Equity | 17,513 | 16,877 | 16,115 | 15,077 | 13,923 | 12,604 |
Total Liabilities & Equity | - | 23,821 | 22,444 | 20,221 | 19,623 | 16,101 |
Total Debt | 1,590 | 1,170 | 327.6 | 798.1 | 439.5 | 27.3 |
Net Cash (Debt) | 127.7 | 922.5 | 1,100 | -611.7 | 757.8 | 3,339 |
Net Cash Growth | -50.16% | -16.14% | - | - | -77.30% | 368.16% |
Net Cash Per Share | 0.44 | 3.14 | 3.75 | -2.08 | 2.58 | 11.45 |
Filing Date Shares Outstanding | 294 | 293.53 | 293.53 | 293.53 | 293.53 | 293.53 |
Total Common Shares Outstanding | 294 | 293.53 | 293.53 | 293.53 | 293.53 | 293.53 |
Working Capital | - | 5,414 | 5,598 | 4,641 | 5,674 | 7,317 |
Book Value Per Share | 59.60 | 57.50 | 54.90 | 51.37 | 47.43 | 42.94 |
Tangible Book Value | 17,374 | 16,742 | 15,989 | 14,988 | 13,889 | 12,602 |
Tangible Book Value Per Share | 59.13 | 57.04 | 54.47 | 51.06 | 47.32 | 42.93 |
Land | - | 1,601 | 1,412 | 704.4 | 560.7 | 422.7 |
Buildings | - | 2,113 | 1,487 | 1,369 | 1,001 | 876.9 |
Machinery | - | 11,566 | 9,320 | 7,848 | 6,034 | 5,431 |
Construction In Progress | - | 208.1 | 998.3 | 814 | 1,020 | 482.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.